Описание

Mechanisms through which Bifidobacteria may modulate eczema risk are outlined, including gut barrier enhancement, immune tolerance induction, and short-chain fatty acid production.

Figure 2

Diagram

Source Paper

The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Eczema and Hypercholesterolemia.

Microorganisms (2021)

PMID: 33919907

DOI: 10.3390/microorganisms9040836

Cite This Figure

![Figure 2: Mechanisms through which Bifidobacteria may modulate eczema risk are outlined, including gut barrier enhancement, immune tolerance induction, and short-chain fatty acid production.]()

> Source: Luisa Marras et al. "The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Ecz." *Microorganisms*, 2021. PMID: [33919907](https://pubmed.ncbi.nlm.nih.gov/33919907/)

<figure>
  <img src="" alt="Mechanisms through which Bifidobacteria may modulate eczema risk are outlined, including gut barrier enhancement, immune tolerance induction, and short-chain fatty acid production." />
  <figcaption>Figure 2. Mechanisms through which Bifidobacteria may modulate eczema risk are outlined, including gut barrier enhancement, immune tolerance induction, and short-chain fatty acid production.<br>  Source: Luisa Marras et al. "The Role of Bifidobacteria in Predictive and Preventive Medicine: A Focus on Ecz." <em>Microorganisms</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33919907/">33919907</a></figcaption>
</figure>

Связанные доказательства

Lactobacillus plantarum для Irritable Bowel Syndrome (IBS)

Оценка B · 5 исследований

Bifidobacterium longum для Irritable Bowel Syndrome (IBS)

Оценка B · 4 исследований

Lactobacillus acidophilus для Irritable Bowel Syndrome (IBS)

Оценка B · 3 исследований